HVT:NYSEHaverty Furniture Companies, Inc. Analysis
Data as of 2026-05-24 - not real-time
$22.35
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Haverty Furniture posted a solid Q1 top‑line beat, with net sales rising 4.1% YoY to $189.1 M and comparable sales up 4.3% for a third straight quarter. Management highlighted higher average ticket sizes, expanding design‑service revenue and a robust 2026 store pipeline, while gross margins are projected to stay near the 60.5‑61% range despite tariff and fuel‑cost headwinds. However, the stock trades at $22.35, well above the DCF‑derived fair value of $9.20 and just under its 200‑day SMA of $23.00, signalling a bearish technical stance. The dividend yield looks attractive at 5.9%, but the payout ratio exceeds 100%, raising concerns about sustainability. With a 30‑day volatility of 37% and a beta around 1.05, the equity is more volatile than the market, and its low ROE (6.6%) and thin operating margin (2.6%) limit upside potential.
Given the over‑extended valuation, unsustainable dividend policy, and bearish price dynamics, the near‑term outlook remains cautious despite the positive earnings momentum.
Given the over‑extended valuation, unsustainable dividend policy, and bearish price dynamics, the near‑term outlook remains cautious despite the positive earnings momentum.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish technical trend (price below SMA‑200 and SMA‑20)
- Overvaluation relative to DCF fair value
- Dividend payout ratio >100% (unsustainable)
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Positive earnings momentum and comparable‑sales growth
- Stable gross margins near 61%
- High volatility and beta indicating price swings
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Potential turnaround from store expansion and design‑service initiatives
- Improving cash flow generation (operating cash flow > free cash flow)
- Long‑term value perception if dividend policy is restructured
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin2.64%
P/E Ratio18.3
ROE6.61%
ROA2.20%
Debt/Equity71.50
P/B Ratio1.2
Op. Cash Flow$43.6M
Free Cash Flow$16.7M
Technical Analysis
TrendBearish
RSI56.5
Support$20.10
Resistance$22.94
MA 20$21.51
MA 50$21.72
MA 200$23.00
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$9.20
Target Price$29.50
Upside/Downside31.99%
GradeOvervalued
TypeValue
Dividend Yield5.91%
Risk Assessment
Beta1.05
Volatility37.05%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.